Safety and Efficacy of the WaisFix100i for Intracapsular Femoral Fracture Fixation
NCT ID: NCT00521716
Last Updated: 2009-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
NA
20 participants
INTERVENTIONAL
2007-09-30
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Performance of BonyPid-1000™ in the Treatment of Gustilo I, II, IIIA and IIIB Tibial Open Fractures
NCT02491047
Using Alternative Implants for the Surgical Treatment of Hip Fractures (The FAITH Study)
NCT00761813
Stabilization of Trochanteric Fracture Using a Screw-plate TRAUMAX
NCT00703716
Osseointegration of Hydroxyapatite-coated Femoral Stems in Femoral Neck Fractures Over 80 Years
NCT04773145
Prosthesis Versus Osteosynthesis in Proximal Tibia Fractures
NCT03172715
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Fractures have been treated with immobilization, traction, amputation, and internal fixation throughout history. Immobilization by casting, bracing, or splinting a joint above and below the fracture was used for most long bone fractures.
Several studies have suggested that reduction and fixation of an Intracapsular fracture of the hip with multiple pins or screws is associated with a lower rate of morbidity and mortality than treatment with prosthetic replacement. With improved methods of fixation and a tendency toward earlier weight-bearing, internal fixation is believed to be a better mode of treatment for younger, more active patients.
On the other hand, the internal fixation procedure may result with number of possibilities for serious complications and biomechanical disadvantages, leading to the device failure. This led to a growing tendency to prefer total or partial hip replacement as the common treatment for intracapsular fracture, although the internal fixation is the favorable procedure in the professional literature.
OrthoMediTec has developed the WaisFix100i device, a new concept for Intracapsular Femoral Fracture Fixation and bone grafting using minimally invasive procedures. The WaisFix100i combines a new and unique Internal Triangular Cage nail fixator and three lag screws.
The Internal Triangular Cage is inserted into the femoral neck as a strong, solid beam structure to guide and hold the screws in place. The cage supplies the structure to hold the bone graft and screws at the fracture site.
The objectives of this single arm, multi-center, prospective study, are to evaluate the safety and efficacy of using the WaisFix100i device in intracapsular femoral fracture fixation surgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Intracapsular Femoral Fracture Fixation
The WaisFix100i combines a new and unique Internal Triangular Cage nail fixator and three lag screws.
WaisFix100i for Intracapsular Femoral Fracture Fixation
The WaisFix100i combines a new and unique Internal Triangular Cage nail fixator and three lag screws.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intracapsular Femoral Fracture Fixation
The WaisFix100i combines a new and unique Internal Triangular Cage nail fixator and three lag screws.
WaisFix100i for Intracapsular Femoral Fracture Fixation
The WaisFix100i combines a new and unique Internal Triangular Cage nail fixator and three lag screws.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age 50 to 75.
3. Subject able to comprehend and give informed consent for participation in this study.
Exclusion Criteria
2. Terminal diseases
3. Patients in high risk and/or acute cardio-vascular disease.
4. Known cognitive disorder, psychiatric and/or neurological disease
5. Physician objection.
6. Age under 50 or above 75.
7. Concurrent participation in any other clinical study
8. Patients cannot understand or not willing to sign the informed consent.
50 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
OrthoMediTec
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
OrthoMediTec
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marc Waisman, Dr.
Role: PRINCIPAL_INVESTIGATOR
Carmel medical Center, Haifa Israel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
carmel Medical Center
Haifa, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WF-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.